Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple sclerosis: etiological mechanisms and future directions.

J D Lutton1, R Winston, T C Rodman

  • 1Institute for Human Genetics and Biochemistry, Cabrini Medical Center, New York, New York 10003, USA. jdlut@frontiernet.net

Experimental Biology and Medicine (Maywood, N.J.)
|January 8, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for the rare decays K(L)→π0π0μ+μ- and K(L)→π0π0X0→π0π0μ+μ-.

Physical review letters·2011
Same author

Comparative effect of heme analogues on hematopoiesis in lymphoproliferative disorders.

Leukemia & lymphoma·2011
Same author

Tailored reflectors for illumination.

Applied optics·2010
Same author

Dielectric totally internally reflecting concentrators.

Applied optics·2010
Same author

Optics of two-stage photovoltaic concentrators with dielectric second stages.

Applied optics·2010
Same author

Throughput of diffraction-limited field optics systems for infrared and millimetric telescopes: erratum.

Applied optics·2010

Multiple sclerosis (MS) is an autoimmune disease targeting myelin basic protein (MBP). This review updates knowledge on MS mechanisms, genetics, immunology, and therapeutic strategies, including oral antigens and antibody therapy.

Area of Science:

  • Neuroimmunology
  • Autoimmune Diseases
  • Molecular Biology

Background:

  • Multiple sclerosis (MS) is a complex autoimmune disease primarily affecting the nervous system.
  • The key pathology involves immunologic destruction of myelin basic protein (MBP).
  • The exact etiology of MS remains largely unknown.

Purpose of the Study:

  • To provide an updated review of the basic mechanisms underlying MS.
  • To discuss current and emerging therapeutic management strategies for MS.
  • To explore the role of MBP structure, genetics, and immunological factors in MS pathogenesis.

Main Methods:

  • Review of existing literature on MS pathogenesis and treatment.
  • Analysis of studies on MBP peptides, genetic contributions, and environmental factors.

Related Experiment Videos

  • Examination of immunological mechanisms, including T-cell regulation and innate immunity.

    • Main Results:

    • MBP peptides are identified as immunodominant antigens in MS patients.
    • Genetic factors and specific haplotypes contribute to MS susceptibility.
    • Regulatory T-cells (Treg) play a crucial role in modulating autoimmune responses, as shown in animal models.

    Conclusions:

    • Understanding MBP structure and immunodominant peptides is key to MS pathogenesis.
    • Regulatory T-cells offer a promising target for therapeutic intervention.
    • Therapeutic strategies like oral antigen therapy (e.g., glatirmer acetate) show potential for managing MS.